Sunshine Biopharma, Inc. (SBFM)
2.71
-0.08
(-2.87%)
USD |
NASDAQ |
Nov 06, 16:00
2.76
+0.05
(+1.85%)
After-Hours: 05:51
Sunshine Biopharma Price to Book Value : 0.0118 for Nov. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 06, 2026 | 0.0118 |
| November 05, 2026 | 0.0121 |
| November 04, 2026 | 0.0115 |
| November 03, 2026 | 0.0119 |
| November 02, 2026 | 0.0119 |
| October 30, 2026 | 0.0127 |
| October 29, 2026 | 0.0144 |
| October 28, 2026 | 0.0135 |
| October 27, 2026 | 0.0128 |
| October 26, 2026 | 0.0115 |
| October 23, 2026 | 0.013 |
| October 22, 2026 | 0.0145 |
| October 21, 2026 | 0.0187 |
| October 20, 2026 | 0.0191 |
| October 19, 2026 | 0.021 |
| October 16, 2026 | 0.0192 |
| October 15, 2026 | 0.02 |
| October 14, 2026 | 0.0211 |
| October 13, 2026 | 0.0205 |
| October 12, 2026 | 0.0262 |
| October 09, 2026 | 0.0293 |
| October 08, 2026 | 0.0373 |
| October 07, 2026 | 0.0607 |
| October 06, 2026 | 0.0345 |
| October 05, 2026 | 0.0364 |
| Date | Value |
|---|---|
| October 02, 2026 | 0.0578 |
| October 01, 2026 | 0.0597 |
| September 30, 2026 | 0.0671 |
| September 29, 2026 | 0.0683 |
| September 28, 2026 | 0.071 |
| September 25, 2026 | 0.0731 |
| September 24, 2026 | 0.0694 |
| September 23, 2026 | 0.076 |
| September 22, 2026 | 0.0786 |
| September 21, 2026 | 0.0789 |
| September 18, 2026 | 0.0781 |
| September 17, 2026 | 0.073 |
| September 16, 2026 | 0.0894 |
| September 15, 2026 | 0.0894 |
| September 14, 2026 | 0.0928 |
| September 11, 2026 | 0.092 |
| September 10, 2026 | 0.0937 |
| September 09, 2026 | 0.0972 |
| September 08, 2026 | 0.0998 |
| September 04, 2026 | 0.0989 |
| September 03, 2026 | 0.0963 |
| September 02, 2026 | 0.1015 |
| September 01, 2026 | 0.098 |
| August 31, 2026 | 0.0972 |
| August 28, 2026 | 0.0998 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.644 |
| Alnylam Pharmaceuticals, Inc. | 5.793 |
| Anika Therapeutics, Inc. | 1.416 |
| Savara, Inc. | 6.906 |
| Vericel Corp. | 7.257 |
Price to Book Value Related Metrics
| PS Ratio | 0.0027 |
| Price | 2.71 |
| Earnings Yield | -7.55K% |
| Market Cap | 0.3236M |